Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist

This publication has 24 references indexed in Scilit:

• A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523
  European Journal of Pharmacology, 1996
• Synthesis and biological evaluation of novel NK-1 tachykinin receptor antagonists: The use of cycloalkyl amino acids as a template
  Biopolymers, 1995
• The mammalian tachykinin receptors
  General Pharmacology: The Vascular System, 1995
• Studies on Neurokinin Antagonists. 4. Synthesis and Structure-Activity Relationships of Novel Dipeptide Substance P Antagonists: N2-[(4R)-4-Hydroxy-1-[(1-methyl-1H-indol-3-yl)carbonyl]-L-prolyl]-N-methyl-N-(phenylmethyl)-3-(2-naphthyl)-L-alaninamide and Its Related Compounds
  Journal of Medicinal Chemistry, 1994
• Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (±)-CP-96,345, and RP 67580) binding
  European Journal of Pharmacology, 1994
• Tachykinin receptors and tachykinin receptor antagonists
  Journal of Autonomic Pharmacology, 1993
• CP-96,345 antagonism of NK1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effects
  European Journal of Pharmacology, 1992
• The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels
  European Journal of Pharmacology, 1992
• Studies on neurokinin antagonists. 1. The design of novel tripeptides possessing glutaminyl-D-tryptophylphenylalanine sequence as substance P antagonists
  Journal of Medicinal Chemistry, 1992
• A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor
  Science, 1991